Supporting SMEs during COVID-19: The case for targeted equity injections

Area of Science:

• Economics
• Financial policy
• Business resilience

Background:

• The COVID-19 crisis posed significant solvency risks to small and medium-sized enterprises (SMEs).
• Government interventions are crucial for mitigating widespread business failures during economic shocks.

Purpose of the Study:

• To analyze the effectiveness and cost-efficiency of equity injections as a policy tool for SMEs facing solvency issues.
• To evaluate the impact of targeted versus untargeted equity injection programs.

Main Methods:

• Utilized firm-level balance sheet projections for European economies.
• Simulated various policy interventions, focusing on equity injections.
• Compared the costs and outcomes of targeted and untargeted approaches.

Main Results:

• Equity injections demonstrated considerable effectiveness in reducing SME insolvencies.
• Targeted equity injections, focusing on viable SMEs, were substantially more cost-effective.
• A targeted program cost approximately one-tenth of an untargeted approach in simulations.

Conclusions:

• Governments should consider targeted equity injections as a primary response to widespread solvency risks.
• Strategic capital support can be a vital tool for enhancing SME resilience after major economic disruptions.
• Policy design, particularly targeting, is critical for maximizing the impact and efficiency of financial support programs.